gvtcx

Secondary Blood Grouping and Sickle Testing

NHS Blood and Transplant Published 25 Jul 2025 Find a Tender

key details

Value£8,655,000
Statusunsuccessful
Category (CPV) 85111810
Deadline10 Jun 2024
Procedureopen
OCIDocds-h6vhtk-040cd2

Awards (3)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £8,655,000.

SupplierValueDateStatus
IBG Immucor Ltd £6,240,000 24 Jul 2025 active
IBG Immucor Ltd · · active
not named · · unsuccessful

description

NHSBT is looking to award a Managed Service Contract for the supply of commercially available automated blood group testing equipment for use as a secondary testing technology for ABO and Rh D typing, antibody screening and identification, extended red cell phenotyping and HbAS (heterozygous sickle cell trait) screening for donor blood, tissues and stem cell (haemopoietic progenitor cells and therapeutic cells) samples.

notice history

5 notices published against this procurement.

PublishedTypeRegimeNotice
17 Oct 2023 Prior information notice (F01) Earlier regulations 030665-2023
9 May 2024 Contract notice (F02) Earlier regulations 014870-2024
25 Jul 2025 Contract award notice (F03) Earlier regulations 043037-2025
25 Jul 2025 Contract award notice (F03) Earlier regulations 043039-2025
25 Jul 2025 Award (award) · 3c8c3bdd-40d2-421b-9782-fa8ec581a872-856124

more from NHS Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.